Johnson & Johnson said on Thursday it has fully enrolled participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate. The study, named Ensemble, has enrolled about 45,000 participants and is being conducted by its unit…
J&J says late-stage COVID-19 vaccine trial fully enrolled
